Stay updated on Long-Term Safety of ZX008 in Epileptic Encephalopathy Clinical Trial
Sign up to get notified when there's something new on the Long-Term Safety of ZX008 in Epileptic Encephalopathy Clinical Trial page.

Latest updates to the Long-Term Safety of ZX008 in Epileptic Encephalopathy Clinical Trial page
- Check6 days agoChange DetectedRemoved 'Dravet syndrome' from the list of conditions in the study details, affecting how the study's scope and eligibility are described.SummaryDifference0.0%

- Check13 days agoChange DetectedAdded a new revision notice 'Revision: v3.5.0' and removed the previous 'Revision: v3.4.3'.SummaryDifference0.1%

- Check20 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check28 days agoChange Detected- No visible additions or deletions; the page content and layout appear unchanged between the two screenshots.SummaryDifference0.1%

- Check35 days agoChange DetectedNo additions or deletions detected in the page snapshot.SummaryDifference0.1%

- Check49 days agoChange DetectedAdded platform revision note v3.4.2 and removed the funding-lapse notice as well as the previous revision note v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Long-Term Safety of ZX008 in Epileptic Encephalopathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of ZX008 in Epileptic Encephalopathy Clinical Trial page.